| NAME |
DIDANOSINE 250MG/PKG SOLN,ORAL |
| VA GENERIC NAME |
DIDANOSINE |
| DOSAGE FORM |
PWDR,RENST-ORAL |
| FDA MED GUIDE |
Didanosine_Powder_(Videx)_(2018).pdf |
| ACTIVE INGREDIENTS |
|
| NATIONAL FORMULARY RESTRICTION |
Refer to HIV/AIDS TAG treatment guidelines
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
250 |
| INACTIVATION DATE |
2007-09-19 00:00:00 |
| UNITS |
MG/PKG |
| DSS NUMBER |
7 |
| NATIONAL FORMULARY NAME |
DIDANOSINE PWDR,RENST-ORAL |
| CREATE DEFAULT POSSIBLE DOSAGE |
YES |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 2
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
DIDANOSINE 250MG/PKG SOLN |
| VA PRODUCT IDENTIFIER |
D0210 |
| TRANSMIT TO CMOP |
YES |
| VA DISPENSE UNIT |
PKT |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4009948 |
| EFFECTIVE DATE/TIME |
-
- 2005-03-10 00:00:00
- STATUS: ACTIVE
-
- 2007-09-19 00:00:00
- STATUS: INACTIVE
|
